Kaken Pharmaceutical Co., Ltd. (TYO:4521)
Japan · Delayed Price · Currency is JPY 3,840.00
-20.00 (-0.52%)
Oct 23, 2026, 3:30 PM JST
Kaken Pharmaceutical Market Cap
Kaken Pharmaceutical has a market cap or net worth of 145.41 billion as of October 23, 2026. It is the 10,504th most valuable company in the world and the 790th biggest in Japan. Its market cap has increased by 3.57% in one year.
Market Cap
145.41B
Enterprise Value
91.12B
Revenue
88.16B
Global Rank
Country Rank
#790 Japan
PE Ratio
14.10
ChartMarket Cap Chart
Since March 26, 1993, Kaken Pharmaceutical's market cap has increased from 118.38B to 145.41B, an increase of 22.84%. That is a compound annual growth rate of 0.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 145.41B | -4.36% |
| Dec 30, 2025 | 152.04B | -11.05% |
| Dec 30, 2024 | 170.93B | 34.53% |
| Dec 29, 2023 | 127.05B | -12.84% |
| Dec 30, 2022 | 145.77B | -8.45% |
| Dec 30, 2021 | 159.22B | 3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 276.64B |
| Nippon Shinyaku | 230.85B |
| Sawai Group Holdings | 199.56B |
| Towa Pharmaceutical | 177.75B |
| Kissei Pharmaceutical | 157.85B |
| Mochida Pharmaceutical | 114.68B |
| Zeria Pharmaceutical | 89.22B |
| KYORIN Pharmaceutical | 64.97B |